Intravesical Liposome Versus Oral Pentosan Polysulfate for Interstitial Cystitis/Painful Bladder Syndrome
Abstract
Purpose:
We evaluated the safety and efficacy of intravesical liposomes, a mucosal protective agent, compared to oral pentosan polysulfate sodium for interstitial cystitis/painful bladder syndrome.
Materials and Methods:
We performed a prospective longitudinal study of the effect of 2 independent treatments (intravesical liposomes and oral pentosan polysulfate sodium) in patients with interstitial cystitis/painful bladder syndrome. Ten possible responses (or measures) to treatment were monitored at 3 time points, including baseline, and weeks 4 and 8. A total of 24 patients with interstitial cystitis/painful bladder syndrome were evaluated in a 1:1 ratio to intravesical liposomes (80 mg/40 cc distilled water) once weekly or to oral pentosan polysulfate sodium (100 mg) 3 times daily for 4 weeks each.
Results:
No patient had urinary incontinence, retention or infection due to liposome instillation. There were no unanticipated adverse events and no significant worsening of symptoms during followup. Statistically significant decreases in urinary frequency and nocturia were observed in each treatment group. Statistically significant decreases in pain, urgency and the O'Leary-Sant symptom score were observed in the liposome group. Decreased urgency in the liposome group had the most profound effect of the ordinal measures.
Conclusions:
Each glycosaminoglycan directed treatment seemed beneficial. Liposome intravesical instillation is safe for interstitial cystitis/painful bladder syndrome with potential improvement after 1 course of therapy for up to 8 weeks. Intravesical liposomes achieved efficacy similar to that of oral pentosan polysulfate sodium. Further large-scale placebo controlled studies are needed. Intravesical liposomes appear to be a promising new treatment for interstitial cystitis/painful bladder syndrome.
References
- 1 : Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol2007; 177: 450. Link, Google Scholar
- 2 : Quantifying symptoms in men with interstitial cystitis/prostatitis, and its correlation with potassium-sensitivity testing. BJU Int2005; 95: 86. Google Scholar
- 3 : Intravesical protamine sulfate and potassium chlorides as a model for bladder hyperactivity. Urology2003; 61: 664. Google Scholar
- 4 : The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol1998; 159: 1862. Link, Google Scholar
- 5 : Treatment of interstitial cystitis. Urology2004; 63: 85. Google Scholar
- 6 : Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier. J Urol1998; 160: 612. Link, Google Scholar
- 7 : Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol1999; 162: 3. Link, Google Scholar
- 8 : Treatment of interstitial cystitis with intravesical heparin. Br J Urol1994; 73: 504. Google Scholar
- 9 : Povidone-iodine liposomes—an overview. Dermatology1997; 195: 93. Google Scholar
- 10 : New frontiers in intravesical therapies and drug delivery. Eur Urol2006; 50: 1183. Google Scholar
- 11 : Recent advances in intravesical drug/gene delivery. Molec Pharmaceut2006; 4: 369. Google Scholar
- 12 : Intravesical liposomes administration: a novel treatment for hyperactive bladder in the rat. Urology2003; 61: 656. Google Scholar
- 13 : The effect of liposome encapsulated antineoplastic agents on transitional cell carcinoma in tissue culture. J Urol1989; 142: 390. Link, Google Scholar
- 14 : The interstitial cystitis symptom index and problem index. Urology1997; 49: 58. Google Scholar
- 15 : Bladder surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science1980; 208: 605. Google Scholar
- 16 : Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int2008; 101: 366. Google Scholar
- 17 : Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes. J Urol2004; 171: 483. Link, Google Scholar
- 18 : Activity of different phospholipids in attenuating hyperactivity in bladder irritation. BJU Int2008; 101: 627. Google Scholar
- 19 : Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol2005; 174: 2235. Link, Google Scholar
- 20 : The management of haemorrhagic cystitis with sodium pentosan polysulphate. BJU Int2004; 94: 845. Google Scholar
- 21 : Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. J Urol1987; 138: 508. Link, Google Scholar
- 22 : Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol1983; 130: 51. Link, Google Scholar
- 23 : Successful therapy of interstitial cystitis with pertosanpolysulfate. J Urol1987; 138: 513. Link, Google Scholar
Department of Urology, Chang Gung Memorial Hospital Kaohsiung, Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan, Republic of China
